Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis

Transplantation

Volumn 69, Issue 3, 2000, Pages 399-405

  Neuringer, Isabel P ^a,c   Walsh, Sean P ^a   Mannon, Roslyn B ^b   Gabriel, Sherif ^a   Aris, Robert M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYCLOSPORIN A; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; LUNG TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRACHEA MUCOSA;

EID: 0033996335     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002150-00016     Document Type: Article

References (50)

1. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997; 155: 789.
2. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 Working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant 1996; 15: 1.
3. International Society for Heart and Lung Transplantation: Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant. 1993; 12: 713.
4. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek mm, and Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: Fifteenth Official Report-1998. J Heart Lung Transplant. 1998; 17: 656.
5. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
6. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection - an undefined conundrum. Transplantation 1991; 52: 389.
7. Rabinowich H, Zeevi A, Paradis IL, et al. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 1990; 49: 115.
8. Duncan SR, Valentine V, Roglic M, et al. T Cell Receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis. J Clin Invest. 1996; 97: 2642.
9. Reinsmoen NL, Bolman RM, Savik K, Butters K, Matas AJ, Hertz MI. Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity. J Heart Lung Transplant. 1994; 13: 30.
10. Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 1993; 142: 1945.
11. Huang X, Reichenspurner H, Shorthouse R, Cao W, Berry G, Morris R. Heterotopic tracheal allograft transplantation: a new model to study the cellular and molecular events causing obliterative airway disease (OAD) in rats (Abstract). J Heart Lung Transplant 1995; 14: S49.
12. King MB, Jessurun J, Savik SK, Murray JJ, Hertz MI. Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model. Transplantation 1997; 63: 528.
13. Fahrni JA, Berry GJ, Morris RE, Rosen GD. Rapamycin inhibits development of obliterative airway disease in a murine heterotopic airway transplant model. Transplantation 1997; 63: 533.
14. Neuringer IP, Mannon R, Coffman T, et al. Immune cells in a mouse airway model of obliterative bronchiolitis. Am J Respir Cell Mol Biol 1998; 19: 379.
15. Kelly KE, Hertz MI, Mueller DI. Localization of the cellular immune response in murine obliterative airways disease. Am J Respir Crit Care Med 1997; 155: A271.
16. Dallman MJ. Cytokines and transplantation: Th1/Th2 regulation of the immune response of the immune response to solid organ transplants in the adult. Curr Opin Immunol 1995; 7: 632.
17. Picotti JR, Chan SY, VanBuskirk AM, Eichwald EJ, Bishop K. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 1997; 63: 619.
18. Sambrook J, Fritsch EF, Maniotis T. Molecular cloning: a laboratory manual. Plainview, NY: Cold Spring Harbor Press, Plainview, NY: 1989: 7.6.
19. Gause WC, and Adamovicz J. Use of the PCR to quantitate gene expression. PCR Methods Appl. 1994; 3: S123.
20. Person, Ron. Using Microsoft Excel 97. 1997. Que Corporation, Indianapolis, IN.
21. Gajewski TF, Schell SR, Fitch F. Evidence implicating utilization of different T cell receptors-associated signaling pathways by Th1 and Th2 clones. J Immunol 1990; 144: 4110.
22. Nickerson P, Steiger J, Zheng XX, et al. Manipulation of cytokine networks in transplantation. Transplantation 1997; 63: 489.
23. Francalancia NA, Wang SC, Thai NL, et al. Graft cytokine mRNA activity in rat single lung transplants by reverse transcription-polymerase chain reaction: effect of cyclosporin. J Heart Lung Transplant. 1992; 11: 1041.
24. Zuo XJ, Matsumura Y, Prehn J, et al. Cytokine gene expression in rejecting and tolerant rat lung allograft models; analysis by RT-PCR. Transplant Immunol 1995; 3: 151.
25. Boehler A, Bai XH, Liu M, et al. Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration. Am J Respir Crit Care Med 1999; 159: 1910.
26. Boehler A, Chamberlain D, Xing Z, et al. Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans. Hum Gene Ther 1998; 9: 541.
27. Matsumura Y, Zuo XJ, Prehn J, et al. Soluble CTLA4Ig modifies parameters of acute inflammation in rat lung allograft rejection without altering lymphocyte infiltration or transcription of key cytokines. Transplantation 1995; 59: 551.
28. Dallman MJ, Larsen CP, Morris P. Cytokine gene transcription in vascularized organ grafts: analysis using semi-quantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
29. Morgan CJ, Pelletier RP, Hernandez CJ, et al. Alloantigen-dependent endothelial phenotype and lymphokine mRNA expression in rejecting murine cardiac allografts. Transplantation 1993; 55: 919.
30. Nagano H, Nadeau KC, Takada M, Kusaka M, Tilney NL. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplantation 1997; 63: 1101.
31. Ozasa T, Newton MR, Dallman MJ, Shimizu S, Gray DWR, Morris P. Cytokine gene expression in pancreatic islet grafts in the rat. Transplantation 1997; 64: 1152.
32. O'Connell PJ, Pacheco-Silva A, Nickerson PW, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093.
33. Russell ME, Wallace AF, Hancock WW, et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 1995; 59: 578.
34. Nadeau KC, Azuma H, Tilney N. Sequential cytokine dynamics in chronic rejection of rat renal allografts: role for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 1995; 92: 8729.
35. Sundaresan S, Alevy YG, Steward N, et al. Cytokine gene transcripts for tumor necrosis factor-α, interleukin-2, and interferon-γ in human pulmonary allografts. J Heart Lung Transplant 1995; 14: 512.
36. Whitehead BF, Stoehr C, Wu CJ, et al. Cytokine gene expression in human lung transplant recipients. Transplantation 1993; 56: 956.
37. Clement MV, Legros-Maida S, Israel-Biet D, et al. Perform and granzyme B expression is associated with severe acute rejection. Transplantation 1994; 57: 322.
38. Kiatboonsri C, Chan KM, Jones CA, et al. Interleukin-4 mRNA transcripts in bronchoalveolar lavage fluid as a predictor for absence of pulmonary allograft rejection. Am J Respir Crit Care Med 1996; 153: A151.
39. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft. Transplantation 1994; 57: 1333.
40. Grant SCD, Guy SP, Lamb WR, Brooks NH, Brenchley PEC, Hutchinson IV. Expression of cytokine messenger RNA after heart transplantation. Transplantation 1996; 62: 910.
41. Legros-Maida S, Soulie A, Benvenuti C, et al. Granzyme B and perforin can be used as predictive markers of acute rejection in heart transplantation. Eur J Immunol 1994; 24: 229.
42. Kummer JA, Wever PC, Kamp AM, ten Berge IJM. Hack CE, Weening J. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Int 1995; 47: 70.
43. Krams SM, Villanueva JC, Quinn MB, Martinez OM. Expression of the cytotoxic T cell mediator granzyme B during liver allograft rejection. Transplant Immunol 1995; 3: 162.
44. Ode-Hakim S, Docke, Kern F, Emmrich F, Volk FD, Reinke P. Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal Allograft recipients. Transplantation 1996; 61: 1233.
45. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695.
46. Van Hoffen E, Gmelig-Meyling FHJ, Bosboom-Kalsbeek KC, et al. Cytokine messenger RNA expression by donor-specific cytotoxic T-cell clones after allogeneic heart transplantation. J Heart Lung Transplant 1997; 16: 216.
47. Hertz MI, Henke CA, Nakhleh RE, et al. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acad Sci USA 1992; 89: 10385.
48. Awad MR, El-Gamel A, Haselton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta 1 gene: association with transforming growth factor-beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66: 1014.
49. El-Gamel AM, Awad E, Sim P, et al. Transforming growth factor-beta 1 and lung allograft fibrosis. Eur J Cardiothorac Surg 1998; 4: 424.
50. Shin GT, Khanna A, Ding R, et al. In vivo expression of transforming growth factor-beta 1 in humans: stimulation by cyclosporine. Transplantation 1998; 65: 313.